2019 - Vol. 6
|Genotoxicity and subchronic toxicity studies of Taiwanofungus camphoratus extract||Vol.6, No.3, p.81-106|
|Jian-Yu Lin , Mei-Chun Chen , Emerson Chiu|
|Released: April 05, 2019|
|Abstract||Full Text PDF[2M]|
Taiwanofungus camphoratus is an edible and medicinal mushroom originating in Taiwan. Several researches have revealed T. camphoratus possessed various biological activities, including anti-cancer, immunomodulation, liver protection and anti-inflammation. Recently, it has been widely used in food supplements and drug development for its health benefits and medicinal properties. Therefore, the safety issue is the primary concern for consumers. The aim of this study was to evaluate the toxicological effects of T. camphoratus extract that was composed of extracts from cut-log cultivated fruiting body and solid-state culture of T. camphoratus. The genotoxicity tests, rodent and non-rodent repeated dose toxicity studies were performed. The results of the genetic toxicology tests including in vitro bacterial reverse mutation assay, in vitro chromosomal aberration test, and in vivo mouse bone marrow micronucleus assay were all negative that indicated neither mutagenicity nor clastogenicity was caused by T. camphoratus extract. Moreover, 13-week and 26-week repeated dose oral toxicity studies in rats showed that no significant adverse effects of T. camphoratus extract were found up to dosages of 3400 mg/kg and 1700 mg/kg for male and female rats, respectively. The results of 28-day repeated dose oral toxicity study in beagle dogs showed no-observed-adverse-effect-level (NOAEL) of T. camphoratus extract up to dosage of 1500 mg/kg for male and female dogs. Accordingly, these results provided the safety information of T. camphoratus extract that supported for using in food supplements or medicinal usage.
|Age-dependent aggravation of oral malodor and periodontal disease in dogs||Vol.6, No.3, p.75-79|
|Naoki Iwashita , Kazutoshi Sugita , Sayaka Murata , Keiko Ichimura , Mitsuyuki Shirai , Masaharu Hisasue , Miyoko Saito , Takuma Aoki , Yukihiko Takagi , Fumitoshi Asai|
|Released: April 04, 2019|
|Abstract||Full Text PDF[743K]|
Halitosis or oral malodor is correlated with the concentration of volatile sulfur compounds (VSCs) produced in the oral cavity by metabolic activity of periodontal pathogenic germs. Our previous study demonstrated that VSCs in canine breath air can be measured using a portable VSC monitor. The aim of this study was to assess the association between oral malodor and periodontal disease in dogs. Forty-three laboratory Beagle dogs (1-16 years of age, 24 males, 19 females) were included in this study. Oral halitosis was evaluated by the organoleptic test score (OS) and by measuring the oral levels of VSCs: hydrogen sulfide (H2S; HS), methyl mercaptan (CH3SH; MM), and dimethyl sulfide (CH3SCH3; DMS) using OralChroma™. The calculus index (CI) and the gingival index (GI) were measured as periodontal parameters. Oral levels of halitosis parameters (OS, HS, MM, CI, and GI) in Group 2 dogs (7-16 years of age) were significantly higher than those in Group 1 dogs (1-6 years of age). In addition, significant positive relationships were found between oral malodor and periodontal disease, both of which are age-dependent in dogs. The present study suggested that aging is an important factor for oral malodor and periodontal disease in dogs.
|Twenty-eight-day oral toxicity study of L-hydroxyproline in rats with 14-day post-treatment observation period||Vol.6, No.3, p.65-74|
|Saori Akiduki , Yoko Kawada , Fumiko Watanabe , Toshikazu Kamiya , Koji Morishita|
|Released: April 04, 2019|
|Abstract||Full Text PDF[1M]|
Repeated-dose oral toxicity of L-hydroxyproline (Hyp) was assessed in male and female SD rats by gavage for 28 days at dose level of 40, 200, 1,000 or 4,000 mg/kg/day. The reversibility of treatment-related changes was also examined by providing 14-day recovery period in the control group and 4,000 mg/kg group. In the results, reduced body weight gain with decreased food consumption was noted in males at 4,000 mg/kg/day. The histopathological evaluation revealed increased incidences of focal dilatation of the renal tubules with narrowing of the tubular cell liner and focal interstitial fibroplasia in the kidney of males at 1,000 and 4,000 mg/kg and females at 4,000 mg/kg. The lack of kidney specific serum chemical or urinalysis findings supported that the renal changes were very mild. Based on the above results, it was concluded that the no observed adverse effect level (NOAEL) of Hyp was 200 mg/kg/day.